Navigation Links
Remarks as Prepared for Delivery By Attorney General Eric Holder at the AstraZeneca Settlement Announcement
Date:4/27/2010

WASHINGTON, April 27 /PRNewswire-USNewswire/ -- The following are remarks as prepared for delivery by Attorney General Eric Holder:

"Over the past 15 months, Secretary Sebelius and I have made it a top priority of both our Departments to crack down on health care fraud, which we know costs taxpayers billions of dollars each year.  Through our Health Care Fraud Prevention and Enforcement Action Team, or HEAT, we have brought the full resources of the federal government to bear against individuals and corporations who illegally divert taxpayer resources for their own gain.

"Today, we are here to announce the latest results of that effort.  The pharmaceutical company AstraZeneca has agreed to pay $520 million to federal and state taxpayers to settle claims that it illegally marketed the anti-psychotic drug Seroquel for uses that were not approved as safe and effective by the Food and Drug Administration.  As part of this scheme, AstraZeneca was accused of illegally promoting Seroquel to physicians and violating the federal Anti-Kickback statute, all in furtherance of supporting the drug's use for a host of illnesses for which it was never approved.

"According to the settlement, AstraZeneca's illegal marketing of the drug led to millions of dollars in false claims against federal and state programs like Medicare and Medicaid. 

"These were not victimless crimes – illegal acts by pharmaceutical companies and false claims against Medicare and Medicaid can put the public health at risk, corrupt medical decisions by health care providers, and take billions of dollars directly out of taxpayers' pockets. 

"As we have said, we will not let such act
'/>"/>

SOURCE U.S. Department of Justice
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee
2. Partnership for Prescription Assistance Prepared to Help Southern Workers Hurt by Recession
3. CareFusion Shipping Ventilators to CDC for National Emergency Preparedness
4. USAID Cooperates in Pandemic Preparedness Initiative
5. The Government of Canada Procures IMVAMUNE(R) Smallpox Vaccine for the Countrys Biological Preparedness
6. Deloitte and Nonprofit Roundtable Host Real-World Disaster Exercise as Next Step in Developing Preparedness Plan for Greater Washington Region
7. Celator(R) Pharmaceuticals Presents New Data on Two Nano-Scale Delivery Platforms at the American Association for Cancer Research
8. PARI Introduces the Vios Aerosol Delivery System
9. Soligenix Announces Issuance of Hong Kong Patent for its LPM(TM) Oral Drug Delivery Technology
10. VELOCITY Broadcasting Introduces HD2PC(SM), the First-Ever High-Definition Direct to PC Delivery of Private Broadcast Television
11. JDRF and BD Collaborate to Improve Insulin Pump Delivery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... LONDON , September 4, 2015 ... HCM) today announces that Hutchison MediPharma Limited ("HMP"), ... endpoint in the second proof-of-concept ("POC") trial of ... lung cancer ("NSCLC") in China ... clearly succeeded in meeting the primary efficacy endpoint ...
(Date:9/3/2015)... -- Report Details Ovarian Cancer Therapies ... and Emerging Opportunities What,s the future for treating ... forecasts those pharmaceutical revenues. There you find outlooks ... explore trends, results, treatments, R&D, and opportunities, seeing ... to 2025 at overall world market, submarket, product ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 ... – Your New Guide to that Market, its R&D and ... want to assess the future of cancer-treating medicines? Visiongain,s new ... helping you stay ahead. There you discover financial data, R&D ... In our analysis you see forecasted sales ...
Breaking Medicine Technology:Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 2Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 3Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 4Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 5Ovarian Cancer Drug Therapy: Companies, R&D and Revenue Forecasts 2015-2025: Recently Approved Treatments Give High Market Potential 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7
... Jan. 30 Tigris Pharmaceuticals,Inc., a privately held ... ascending dose clinical study of aminoflavone,pro-drug (AFP-464) for ... dosed,in December 2007 and enrollment is ongoing., ... determine the dose limiting,toxicity (DLT) and maximum tolerated ...
... Product Urokinase and Evaluates Strategic ... Development Program, TUCSON, Ariz. Jan. 30 ImaRx ... will emphasize growing the,market for urokinase in contrast to ... additional value-creating opportunities for,urokinase was made possible by the ...
Cached Medicine Technology:Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors 2Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors 3ImaRx Therapeutics Transitions Business Strategy 2ImaRx Therapeutics Transitions Business Strategy 3ImaRx Therapeutics Transitions Business Strategy 4ImaRx Therapeutics Transitions Business Strategy 5
(Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, a ... announced its only mission and research focus: Water Life Science®. In the current ... water evaporation is becoming dangerously accelerated. As a result of the global fresh ...
(Date:9/4/2015)... , ... September 04, 2015 , ... Having access to ... has led to an increasing amount of unnecessary emergency room visits which affects hospitals’ ... taxes the country’s health bill. Fortunately, a solution to alleviate this problem has recently ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... Residence in South Glastonbury, Connecticut, has been selected for the Residential Award of ... energy efficiency and resiliency measures. Chosen from a highly competitive field of submissions, ...
(Date:9/4/2015)... Charlotte, NC (PRWEB) , ... September 04, 2015 ... ... water filtration products, has a Labor Day offer that cannot be passed up. ... to stock up on necessary air and water filtration product replacements. Take advantage ...
(Date:9/3/2015)... , ... September 04, 2015 , ... AlignLife of ... September. , "There are so many children and adults who don't have the ... Dr. Sara Mahalko-Leonhardt. "We love holding our annual Coat Drive to help those in ...
Breaking Medicine News(10 mins):Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:South Glastonbury Home Selected for Award by Connecticut Green Building Council 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:AlignLife is Helping to Keep the Community Warm This Winter 2
... motor disease, , WEDNESDAY, March 10 (HealthDay News) -- ... smoke and Parkinson,s disease, researchers have found that smoking ... but smoking a large number of cigarettes a day ... had suggested that smokers have a lower risk of ...
... technological revolution, the "light fantastic" continues to impact people,s ... and performing intricate surgery. As the golden anniversary of ... 7th, Chemical & Engineering News (C&EN), ACS, weekly newsmagazine, ... exciting future of this amazing invention. C&EN ...
... ... HBS Alumnus Recognized for PrescriptionDrugs.com Business Plan , ... Boston, MA (PRWEB) March 11, 2010 -- A week ... their first ever HBS Alumni New Venture Contest . PrescriptionDrugs.com co-founder Mike “Zappy” ...
... A clinical research trial of a new treatment to ... safety stage, according to the UC Irvine neurologist who led ... no ill effects after the sequential administration of growth factors ... brain. All new drug treatments must pass this safety stage ...
... ... ... ... ...
... ... ... ... ...
Cached Medicine News:Health News:Longtime Smokers May Find Protection From Parkinson's 2Health News:PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest 2Health News:PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest 3Health News:New Consumer Era Places Retailers at the Forefront of Participating in Shoppers' Health 2Health News:New Consumer Era Places Retailers at the Forefront of Participating in Shoppers' Health 3Health News:New Consumer Era Places Retailers at the Forefront of Participating in Shoppers' Health 4Health News:Visionworks(R) Provides Eye Care For Pittsburgh's Smiling Irish Eyes 2Health News:Visionworks(R) Provides Eye Care For Pittsburgh's Smiling Irish Eyes 3
... The Classic is a ... designed for use by people ... the easy-to-use picture control selector, ... materials in high-contrast black text ...
... magnifier (model CLCM) was designed especially for ... to see objects at a distance as well ... camera design allows viewing at near, intermediate and ... between near and distant viewing. With its included ...
... Maxport is a powerful magnifier that helps the partially ... of a hand magnifier attached to a pair of ... is no need for a TV set. The display ... images on a book, a can of food, a ...
... electronic magnification system. It was designed with ... patient in mind. PVA contains many new ... you to see your face to shave ... pixel full color camera. It connects easily ...
Medicine Products: